A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Public ClinicalTrials.gov record NCT05941442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Study identification
- NCT ID
- NCT05941442
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Darigabat Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2023
- Primary completion
- Mar 30, 2025
- Completion
- Mar 30, 2025
- Last update posted
- May 6, 2026
2023 – 2025
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix, Arizona | Phoenix | Arizona | 85012 | — |
| Lafayette, California | Lafayette | California | 94549 | — |
| Los Angeles, California | Los Angeles | California | 90025 | — |
| Oceanside, California | Oceanside | California | 92056 | — |
| Orange, California | Orange | California | 92868 | — |
| Riverside, California | Riverside | California | 92506 | — |
| San Jose, California | San Jose | California | 95124 | — |
| Torrance, California | Torrance | California | 90502 | — |
| Miami, Florida | Miami | Florida | 33175 | — |
| North Miami Beach, Florida | North Miami Beach | Florida | 33162 | — |
| Orlando, Florida | Orlando | Florida | 32807 | — |
| Atlanta, Georgia | Atlanta | Georgia | 30331 | — |
| Decatur, Georgia | Decatur | Georgia | 30030 | — |
| Savannah, Georgia | Savannah | Georgia | 31405 | — |
| Elgin, Illinois | Elgin | Illinois | 60123 | — |
| Overland Park, Kansas | Overland Park | Kansas | 66210 | — |
| Boston, Massachusetts | Boston | Massachusetts | 02131 | — |
| Las Vegas, Nevada | Las Vegas | Nevada | 89102 | — |
| Berlin, New Jersey | Berlin | New Jersey | 08009 | — |
| Brooklyn, New York | Brooklyn | New York | 11229 | — |
| Brooklyn, New York | Brooklyn | New York | 11235 | — |
| New York, New York | New York | New York | 10016 | — |
| Rochester, New York | Rochester | New York | 14618 | — |
| Staten Island, New York | Staten Island | New York | 10314 | — |
| Monroe, North Carolina | Monroe | North Carolina | 28112 | — |
| Oklahoma City, Oklahoma | Oklahoma City | Oklahoma | 73112 | — |
| West Chester, Pennsylvania | West Chester | Pennsylvania | 19380 | — |
| Austin, Texas | Austin | Texas | 78737 | — |
| Desoto, Texas | DeSoto | Texas | 75115 | — |
| Draper, Utah | Draper | Utah | 84020 | — |
| Everett, Washington | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05941442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05941442 live on ClinicalTrials.gov.